00000nam 2200000zi 4500 9.931658 CaOODSP 20240108150927 m o d f cr mn||||||||| 231220e202308 onca ob f000 0 eng d 9780660693842 CaOODSP eng rda CaOODSP n-cn--- y1y2 HP5-177/2023E-PDF Horizontal evaluation of the Canadian Drugs and Substances Strategy : evaluation report / prepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. Ottawa, ON : Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, August 2023. 1 online resource (87 pages) : colour illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Évaluation horizontale de la Stratégie canadienne sur les drogues et autres substances : rapport d'évaluation. "Pub.: 230565"--Verso of cover. Includes bibliographical references (pages 77-87). "Canada is experiencing an unprecedented rate of substance use-related deaths and harms due to a number of complex, interrelated factors. The Canadian Drugs and Substances Strategy (CDSS), which was first announced in 2016, sets out the federal government's comprehensive, collaborative, compassionate, and evidence-based approach to drug policy that focuses on substance use as a public health issue. The CDSS replaced the National Anti-Drug Strategy (NADS), which was established in 2006, and the lead changed from the Department of Justice to Health Canada. From 2017 to 2022, Health Canada coordinated federal investments and activities across the full spectrum of legal and illegal substances under four pillars: prevention, treatment, harm reduction, and enforcement. ... This evaluation looked at all funded partners' activities from 2017-18 to 2021-22 under both horizontal initiatives and focused on progress made toward delivering on Pillar objectives and shared outcomes, including HC's Substance Use and Addictions Program (SUAP) and PHAC's Harm Reduction Fund activities to address Financial Administration Act requirements. However, activities related to tobacco and cannabis, including SUAP projects for these substances, were excluded from this evaluation as there were separate evaluations assessing activities related to these two substances"--Executive summary, page 5. Drug abuse Government policy Canada Evaluation. Substance abuse Government policy Canada Evaluation. Drug abuse Canada Prevention Evaluation. Substance abuse Canada Prevention Evaluation. Drug abuse Treatment Canada Evaluation. Substance abuse Treatment Canada Evaluation. Canada. Health Canada. Office of Audit and Evaluation, issuing body. Public Health Agency of Canada. Office of Audit and Evaluation, issuing body. Évaluation horizontale de la Stratégie canadienne sur les drogues et autres substances : (CaOODSP)9.931660 PDF 1.53 MB https://publications.gc.ca/collections/collection_2024/sc-hc/HP5-177-2023-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/evaluation/canadian-drugs-substances-strategy.html 230559